Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced record sales leads generated from the presentation of recently rele…
Category: News
Patients Older Than 50 At Higher Risk For Cataract Formation After DSEK
Patients older than 50 years had higher rates of cataract formation and extraction after Descemet’s stripping endothelial keratoplasty than the general population, a study showed.
MedInformatix Practice Management And Electronic Medical Records Solution Enhances And Streamlines Grey Eye Care Claims, Billing And Scheduling Functions
When Grey Eye Care pc sought to replace its outdated server seven years ago, all of the practice’s medical records were paper-based, resulting in an ever-expanding avalanche of inefficient claims, billing and medical reports that sometimes buried offic…
Celtic Therapeutics And Resolvyx Pharmaceuticals Announce An Alliance In Ophthalmology
Celtic Therapeutics Holdings L.P. (Celtic Therapeutics), a successor firm to Celtic Pharma, and Resolvyx Pharmaceuticals, Inc. (Resolvyx) announced today that they have entered into an option agreement relating to Resolvyx’s RX-10045, a late-stage prog…
Treatment of Seasonal Allergic Conjunctivitis With Ophthalmic Corticosteroids: In Search of the Perfect Ocular Corticosteroids in the Treatment of Allergic Conjunctivitis
Learn more about the newer ophthalmic corticosteroid formulations for conjunctivitis and their improved safety profile. Current Opinion in Allergy and Clinical Immunology
Telescope Implant Improves Vision in Macular Degeneration
A recently approved intraocular implant device containing a telescope is for select patients with end-stage age-related macular degeneration. Medscape Medical News
Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma
New structured abstract in the Database of Abstracts of Reviews of Effects from the Centre for Reviews and Dissemination
Second-eye cataract surgery in elderly women – a cost-utility analysis conducted alongside a randomized controlled trial
New abstract in the Health Technology Assessment (HTA) Database from the Centre for Reviews and Dissemination.
Central Retinal Thickness Measured With HD-OCT Shows a Weak Correlation With Visual Acuity in Eyes With CSME
What is the connection between retinal thickness and visual acuity in patients with clinically significant macular edema and type 2 diabetes? The British Journal of Ophthalmology
FDA Approves First Once-Daily Ophthalmic NSAID for Use in Cataract Surgery
The FDA has approved a once-daily formulation of bromfenac 0.09% ophthalmic solution for the treatment of postoperative inflammation and the reduction of ocular pain. Medscape Medical News
Localized Retinoblastoma Treatment Spares Most Eyes, With Low Toxicity
Low-dose chemotherapy delivered directly to the ophthalmic artery is showing efficacy, low toxicity, and an eye salvage rate of more than 90% in retinoblastoma. Medscape Medical News
Statement from AAO regarding “Poppers” and Potential Retinal Damage
A letter by French ophthalmologists, published in the October 14, 2010 issue of the New England Journal of Medicine, described eye and vision damage related to the use of poppers The American Academy of Ophthalmology urges the public to avoid the use…
Anorexia Nervosa May Cause Serious Harm to Patients’ Eyes
The eating disorder anorexia nervosa (AN) can lead to eye damage, possibly of a serious nature, according to an article published online October 20 in the British Journal of Ophthalmology. As many as 3% of middle- and upper-class women, the majority …
Report on Global Ophthalmology Drug and Devices Market
Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. Wit…
Driving Ability Improved After Ranibizumab Therapy in Patients With Macular Degeneration
Monthly intravitreal injections with the VEGF antagonist ranibizumab reduces self-reported difficulty driving in patients with age-related macular degeneration. Medscape Medical News
Synexus Sets Its Sights on Ophthalmology
Synexus is set to take part in a number of global ophthalmology trials following recent investment in clinical research expertise and technology in this area. Chief Executive, Dr Christophe Berthoux says that ophthalmology offers considerable growth …
Novartis’ Vasella elected chairman at Alcon
Novartis’ chairman Daniel Vasella was elected board chairman of Alcon, increasing the Swiss drugmaker’s grip of the U.S. eyecare company as it tries to buy the stake it does not already own. Alcon’s Independent Director’s Committee (IDC), which has r…
AAO: Can Boomers Throw Away Their Reading Glasses? (CME/CE)
CHICAGO (MedPage Today) — With the baby-boom generation now firmly in the age range when near-range vision goes blurry, advances in refractive surgery and implants could allow many of them to do away with reading glasses, researchers said here.
Report on global ophthalmology drug and devices market
Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With …
UCI scientists receive CIRM grants to improve stem cell treatments
UC Irvine scientists will receive grants totaling $9.35 million to help create stem cell treatments for retinitis pigmentosa, Huntington’s disease and traumatic brain injury.